Bicara Therapeutics to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Aug 27, 2025
BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that management will participate in multiple upcoming investor conferences:
Read more at globenewswire.com
